Biyo Pharma Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $14.3M

  • Investors
  • 8

Biyo Pharma General Information

Description

Developer of innovative drug designed for nervous system disease. The company focuses on the research and development of nervous system disease related drugs for episodic migraine and chronic migraine symptoms, providing patients with better medical treatment.

Contact Information

Website
www.biyopharma.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 817, Building 1, Chuanchuan Science and Technology Innovation Building Ningwei Street
  • Xiaoshan District
  • Hangzhou, Zhejiang 620000
  • China
+86 130
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Room 817, Building 1, Chuanchuan Science and Technology Innovation Building Ningwei Street
  • Xiaoshan District
  • Hangzhou, Zhejiang 620000
  • China
+86 130

Biyo Pharma Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biyo Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 13-Jan-2026 $14.3M Completed Pre-Clinical Trials
2. Early Stage VC 21-Jul-2025 Completed Product Development
1. Early Stage VC 26-Apr-2024 Completed Product Development
To view Biyo Pharma’s complete valuation and funding history, request access »

Biyo Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biyo Pharma Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Shanghai Healthcare Capital PE/Buyout Minority
Hangzhou Capital Government Minority
Lapam Capital Venture Capital Minority
Shanghai Industrial Capital Management Growth/Expansion Minority
Hangzhou Tailong Venture Capital Partnership Growth/Expansion Minority
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial

Biyo Pharma FAQs

  • When was Biyo Pharma founded?

    Biyo Pharma was founded in 2021.

  • Where is Biyo Pharma headquartered?

    Biyo Pharma is headquartered in Hangzhou, China.

  • What is the size of Biyo Pharma?

    Biyo Pharma has 5 total employees.

  • What industry is Biyo Pharma in?

    Biyo Pharma’s primary industry is Drug Discovery.

  • Is Biyo Pharma a private or public company?

    Biyo Pharma is a Private company.

  • What is Biyo Pharma’s current revenue?

    The current revenue for Biyo Pharma is .

  • How much funding has Biyo Pharma raised over time?

    Biyo Pharma has raised $14.3M.

  • Who are Biyo Pharma’s investors?

    Shanghai Healthcare Capital, Hangzhou Capital, Lapam Capital, Shanghai Industrial Capital Management, and Hangzhou Tailong Venture Capital Partnership are 5 of 8 investors who have invested in Biyo Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process